A doctor's letter written more than 400 years ago has revealed medics were even then concerned about the dangers of young people smoking.
The letter, by Dr. Eleazar Duncon, concluded that tobacco "is so hurtful and dangerous to youth ... that it was as well known by the name of Youths-bane as by the name of tobacco.”
The letter was unearthed by library staff at the Royal College of Physicians of Edinburgh (RCPE) as they prepared for an exhibition. Professor Sir Neil Douglas, the president of the RCPE, said that the letter "provides a fascinating insight into historical medical concerns about the addictive nature of smoking and young people, and shows that this issue has been of concern for over four centuries."
Sources: Mercola.com newsletter, STV September 20, 2009
Sunday, November 29, 2009
Sunday, November 8, 2009
Would You Actually Get These New Vaccines?
1. AIDS vaccine - A storm has erupted over the announcement last month that an experimental AIDS vaccine tested in Thailand proved modestly effective. It was billed as a major scientific advance — the long-awaited hard evidence that it is possible to inoculate people against AIDS. But now the trial has been called into question in a way that is overblown and possibly destructive.
But this isn’t the first time the efficacy and safety of a vaccine has been called into question. The government recently announced that $10 million of stimulus money would be used to fund a phase 3 clinical trial of a promising anti-smoking vaccine produced by Nabi Pharmaceuticals of Rockville, Md. However, another company working on a similar vaccine has not been so successful.
2. Stop Smoking vaccine - Cytos Biotechnology Ltd. said this week that a trial of its nicotine vaccine had failed to reduce smoking behaviors. The study, which is continuing, involved 200 smokers who were motivated to quit. The researchers found that the vaccine, designed to bind nicotine in the blood and prevent it from reaching the brain, was safe and well tolerated. But apparently it did not stimulate high enough levels of antibodies to produce the desired response.
3. Obesity vaccine - The moment evidence was found that obesity may be linked to a virus, opportunistic drug company researchers dove into developing an “obesity vaccine.” Now researchers say their obesity vaccine could be ready for market in five years. Searching for genetic clues to the obesity epidemic, in the hopes of developing a vaccine against it, is not the answer.
Sources: mercola.com
Posted by: Dr. Dan Thibodeau, contact me at 920-954-1002 or DrDan1221@yahoo.com if you have questions or comments.
But this isn’t the first time the efficacy and safety of a vaccine has been called into question. The government recently announced that $10 million of stimulus money would be used to fund a phase 3 clinical trial of a promising anti-smoking vaccine produced by Nabi Pharmaceuticals of Rockville, Md. However, another company working on a similar vaccine has not been so successful.
2. Stop Smoking vaccine - Cytos Biotechnology Ltd. said this week that a trial of its nicotine vaccine had failed to reduce smoking behaviors. The study, which is continuing, involved 200 smokers who were motivated to quit. The researchers found that the vaccine, designed to bind nicotine in the blood and prevent it from reaching the brain, was safe and well tolerated. But apparently it did not stimulate high enough levels of antibodies to produce the desired response.
3. Obesity vaccine - The moment evidence was found that obesity may be linked to a virus, opportunistic drug company researchers dove into developing an “obesity vaccine.” Now researchers say their obesity vaccine could be ready for market in five years. Searching for genetic clues to the obesity epidemic, in the hopes of developing a vaccine against it, is not the answer.
Sources: mercola.com
Posted by: Dr. Dan Thibodeau, contact me at 920-954-1002 or DrDan1221@yahoo.com if you have questions or comments.
Subscribe to:
Posts (Atom)